REALWAVE NEUROPATHY TREATMENT CENTERS Trademark
Trademark Overview
On Tuesday, September 14, 2021, a trademark application was filed for REALWAVE NEUROPATHY TREATMENT CENTERS with the United States Patent and Trademark Office. The USPTO has given the REALWAVE NEUROPATHY TREATMENT CENTERS trademark a serial number of 97027162. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Amylase Technologies LLC. The REALWAVE NEUROPATHY TREATMENT CENTERS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical diagnosis and treatment of peripheral neuropathy; Medical diagnosis of peripheral neuropathy; Medical evaluation of peripheral neuropathy; Medical services, namely, evaluation and treatment of peripheral neuropathy; Medical testing for diagnostic or treatment purposes in the field of peripheral neuropathy; Medical treatment of peripheral neuropathy
General Information
Serial Number | 97027162 |
Word Mark | REALWAVE NEUROPATHY TREATMENT CENTERS |
Filing Date | Tuesday, September 14, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 25, 2022 |
Registration Number | 6883560 |
Registration Date | Tuesday, October 25, 2022 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 9, 2022 |
Trademark Statements
Description of Mark | The mark consists of the term "REALWAVE" in a distinctive font in which the letter "A" appears as an inverted "V", and the letter "W" is depicted in a stylized form representing a sine wave, above a horizontal line below which appear the terms "NEUROPATHY TREATMENT CENTER." |
Goods and Services | Medical diagnosis and treatment of peripheral neuropathy; Medical diagnosis of peripheral neuropathy; Medical evaluation of peripheral neuropathy; Medical services, namely, evaluation and treatment of peripheral neuropathy; Medical testing for diagnostic or treatment purposes in the field of peripheral neuropathy; Medical treatment of peripheral neuropathy |
Disclaimer with Predetermined Text | "NEUROPATHY TREATMENT CENTERS" |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 20, 2021 |
Primary Code | 044 |
First Use Anywhere Date | Tuesday, May 4, 2021 |
First Use In Commerce Date | Tuesday, May 4, 2021 |
Trademark Owner History
Party Name | Amylase Technologies LLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Billings, MT 59102 |
Party Name | Amylase Technologies LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Billings, MT 59102 |
Party Name | Amylase Technologies LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Billings, MT 59102 |
Trademark Events
Event Date | Event Description |
Tuesday, October 25, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, October 25, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 9, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 9, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, July 20, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, June 21, 2022 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, June 21, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, June 21, 2022 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, June 21, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, June 16, 2022 | ASSIGNED TO EXAMINER |
Thursday, October 21, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, October 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Friday, September 17, 2021 | NEW APPLICATION ENTERED IN TRAM |